Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the completion of its one-millionth DNA/RNA test, underscoring the ...

A small change to a powerful molecular tool — using the CRISPR-Cas13 enzyme, which can detect RNA from viruses and cells — ...

With the rise of DNA ancestry tests, it’s easier than ever to learn about your family history and connections. Today, there are many DNA testing services to choose from. They're easy to use. You’ll ...

CLEVELAND, Ohio—Case Western Reserve University researchers have developed a new method of DNA testing—one they say could greatly expand its uses in medical research. The method rapidly and accurately ...

According to Needham, Lucid Diagnostics Inc. (NASDAQ:LUCD) is likely to receive approval for EsoGuard testing-related Medicare reimbursement, which would boost testing volumes. The Lucid Diagnostics ...

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...

The DNA Diagnostics Market is poised for growth due to increasing chronic and infectious diseases. Opportunities lie in next-generation sequencing advancements and oncology diagnostics, driven by ...